Los Angeles, CA – Patent attorneys filed a patent infringement lawsuit, in Los Angeles Federal District Court, on behalf of Bella Bella, Inc. against numerous cosmetic products manufacturers for allegedly infringing a patent covering a cosmetic composition used in micro-dermabrasion procedures. Bella is the assignee of U.S. Patent No. 6,290,976 titled “Facial skin dermabrasion cleansing and conditioning composition.” The complaint alleges that each of the laundry list of defendants “has infringed and continues to infringe the ‘976 patent by making, using, providing, offering to sell, and selling … microdermabrasion products containing alumina.” Bella alleges that some of the defendants were aware of the ‘976 patents because it had been cited as prior art in the defendants’ own patent application. Also, as to some of the other defendants, Bella alleges that they were aware of the ‘976 patent because Bella had contacted them to offer a license to practice the invention. Bella seeks a permanent injunction in addition to monetary damages for patent infringement. The case is titled Bella Bella, Inc. v. Neutrogena Corporation, et al., CV08-01270 GAF (C.D. California).
Here’s the list of the “et al.” defendants, if you’re interested: Johnson & Johnson, DermAnew, Inc., Sharper Image, Physicians Formula Holdings, Inc., Physicians Formula Cosmetics, Inc., American International Industries, Guthy-Renker Corporation, Stearn’s Products, Inc., Derma E, L’Oreal S.A., L’Oreal USA, Inc., Laboratories Garnier Paris, Garnier LLC, Lancome Perfumes et Beaute, Avon Products, Inc., Mary Kay, Inc., Graf Skin Care, Inc., Homedics-U.S.A., Inc., Borghese, Inc., Photomedex, Inc., Procyte Corporation, Kao Brands, Beauticontrol, Inc., ABBE Laboratories, Inc., Guinot, Lachman Imports, Inc., Estee Lauder Companies, Inc., Prescriptives, Inc., Peter Thomas Roth, Inc., Platinum Skin Care, and, LAST BUT NOT LEAST, Cosmesis Skincare, Inc.